Dr. Velasquez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1001 Potrero Ave
Bldg 80, Ward 84
San Francisco, CA 94110
Education & Training
- Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 2013 - 2015
- Brigham and Womens HospitalResidency, Global Health Equity, 2010 - 2013
- Brigham and Women's HospitalResidency, Internal Medicine, 2009 - 2013
- Northwestern University The Feinberg School of MedicineClass of 2009
Certifications & Licensure
- CA State Medical License 2021 - 2025
- MA State Medical License 2013 - 2022
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 1 citationsCharacteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic ...Anthony J Garcia-Prats, Maria Garcia-Cremades, Vivian Cox, Tamara Kredo, Rory Dunbar
The Lancet. Child & Adolescent Health. 2025-02-01 - Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis.Lorenzo Guglielmetti, Uzma Khan, Gustavo E Velásquez, Maelenn Gouillou, Amanzhan Abubakirov
The New England Journal of Medicine. 2025-01-30 - Person-centred language for describing stratified approaches to TB treatment.M Nash, A Deluca, E Lessem, N West, L McKenna
IJTLD Open. 2025-01-01
Professional Memberships
- Member
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: